50% off Premium Yearly

CVE:NDVA
Medical cannabis. The stock hasn't performed well lately, nor has the sector. The small- and medium-sized cannabis companies have underperformed compared to the big ones. There are worries about too much supply in the market. He likes NDVA and was a past pick. Management has executed as planned by growing their facility. The market isn't rewarding them. Overall, there's a finite number of dollars to invest in cannabis, so money has left the smaller guys over supply fears to invest in the big guys.